MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
55.00
-0.66 (-1.18%)
Aug 14, 2025, 1:42 PM - Market open
MLTX Market Cap
MLTX has a market cap or net worth of $3.49 billion as of August 14, 2025. Its market cap has increased by 28.78% in one year.
Market Cap
3.49B
Enterprise Value
3.16B
1-Year Change
28.78%
Ranking
Category
Stock Price
$55.00
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $3.49B, an increase of 96,959.00%. That is a compound annual growth rate of 615.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 3.53B | 3.48% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 579.44B |
| Johnson & Johnson | 414.48B |
| AbbVie | 349.39B |
| UnitedHealth Group | 235.16B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.97B |
| Novo Nordisk | 222.88B |